BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 27722406)

  • 1. Development of a controlled-release drug delivery system by encapsulating oxaliplatin into SPIO/MWNT nanoparticles for effective colon cancer therapy and magnetic resonance imaging.
    Lee PC; Lin CY; Peng CL; Shieh MJ
    Biomater Sci; 2016 Nov; 4(12):1742-1753. PubMed ID: 27722406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PEGylated multi-walled carbon nanotubes for encapsulation and sustained release of oxaliplatin.
    Wu L; Man C; Wang H; Lu X; Ma Q; Cai Y; Ma W
    Pharm Res; 2013 Feb; 30(2):412-23. PubMed ID: 22992831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multifunctional reduction-responsive SPIO&DOX-loaded PEGylated polymeric lipid vesicles for magnetic resonance imaging-guided drug delivery.
    Wang S; Yang W; Du H; Guo F; Wang H; Chang J; Gong X; Zhang B
    Nanotechnology; 2016 Apr; 27(16):165101. PubMed ID: 26941226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doxorubicin-modified magnetic nanoparticles as a drug delivery system for magnetic resonance imaging-monitoring magnet-enhancing tumor chemotherapy.
    Liang PC; Chen YC; Chiang CF; Mo LR; Wei SY; Hsieh WY; Lin WL
    Int J Nanomedicine; 2016; 11():2021-37. PubMed ID: 27274233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IONP-doped nanoparticles for highly effective NIR-controlled drug release and combination tumor therapy.
    Fu X; Wang X; Zhou S; Zhang Y
    Int J Nanomedicine; 2017; 12():3751-3766. PubMed ID: 28553112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-controlled release of Oxaliplatin prodrug from d-α-tocopheryl polyethylene glycol 1000 succinate (TPGS) functionalized mesoporous silica nanoparticles for cancer therapy.
    Liang C; Wang H; Zhang M; Cheng W; Li Z; Nie J; Liu G; Lian D; Xie Z; Huang L; Zeng X
    J Colloid Interface Sci; 2018 Sep; 525():1-10. PubMed ID: 29679795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biodistribution of biodegradable polymeric nano-carriers loaded with busulphan and designed for multimodal imaging.
    Asem H; Zhao Y; Ye F; Barrefelt Å; Abedi-Valugerdi M; El-Sayed R; El-Serafi I; Abu-Salah KM; Hamm J; Muhammed M; Hassan M
    J Nanobiotechnology; 2016 Dec; 14(1):82. PubMed ID: 27993139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biocompatible APTES-PEG modified magnetite nanoparticles: effective carriers of antineoplastic agents to ovarian cancer.
    Javid A; Ahmadian S; Saboury AA; Kalantar SM; Rezaei-Zarchi S; Shahzad S
    Appl Biochem Biotechnol; 2014 May; 173(1):36-54. PubMed ID: 24615524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PEGylated PAMAM dendrimers loading oxaliplatin with prolonged release and high payload without burst effect.
    Ho MN; Bach LG; Nguyen DH; Nguyen CH; Nguyen CK; Tran NQ; Nguyen NV; Hoang Thi TT
    Biopolymers; 2019 Jul; 110(7):e23272. PubMed ID: 30897210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PEGylated TNF-related apoptosis-inducing ligand (TRAIL)-loaded sustained release PLGA microspheres for enhanced stability and antitumor activity.
    Kim TH; Jiang HH; Park CW; Youn YS; Lee S; Chen X; Lee KC
    J Control Release; 2011 Feb; 150(1):63-9. PubMed ID: 21062635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One-pot facile synthesis of PEGylated superparamagnetic iron oxide nanoparticles for MRI contrast enhancement.
    Dai L; Liu Y; Wang Z; Guo F; Shi D; Zhang B
    Mater Sci Eng C Mater Biol Appl; 2014 Aug; 41():161-7. PubMed ID: 24907749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of dual-functional targeting probes for cancer theranostics based on iron oxide nanoparticles coated by centipede-like polymer connected with pH-responsive anticancer drug.
    Zhao H; Li Z; Yang B; Wang J; Li Y
    J Biomater Sci Polym Ed; 2015; 26(16):1178-89. PubMed ID: 26249213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-type-dependent vascular permeability constitutes a potential impediment to the therapeutic efficacy of liposomal oxaliplatin.
    Abu Lila AS; Matsumoto H; Doi Y; Nakamura H; Ishida T; Kiwada H
    Eur J Pharm Biopharm; 2012 Aug; 81(3):524-31. PubMed ID: 22554766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PEGylated graphene oxide/Fe3O4 nanocomposite: Synthesis, characterization, and evaluation of its performance as de novo drug delivery nanosystem.
    Jafarizad A; Taghizadehgh-Alehjougi A; Eskandani M; Hatamzadeh M; Abbasian M; Mohammad-Rezaei R; Mohammadzadeh M; Toğar B; Jaymand M
    Biomed Mater Eng; 2018; 29(2):177-190. PubMed ID: 29457592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doxorubicin-Conjugated Heparin-Coated Superparamagnetic Iron Oxide Nanoparticles for Combined Anticancer Drug Delivery and Magnetic Resonance Imaging.
    Yang Y; Guo Q; Peng J; Su J; Lu X; Zhao Y; Qian Z
    J Biomed Nanotechnol; 2016 Nov; 12(11):1963-74. PubMed ID: 29363935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multifunctional pH-sensitive superparamagnetic iron-oxide nanocomposites for targeted drug delivery and MR imaging.
    Zhu L; Wang D; Wei X; Zhu X; Li J; Tu C; Su Y; Wu J; Zhu B; Yan D
    J Control Release; 2013 Aug; 169(3):228-38. PubMed ID: 23485450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superparamagnetic iron oxide nanoparticles conjugated with folic acid for dual target-specific drug delivery and MRI in cancer theranostics.
    Huang Y; Mao K; Zhang B; Zhao Y
    Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):763-771. PubMed ID: 27770953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Superparamagnetic iron oxide nanotheranostics for targeted cancer cell imaging and pH-dependent intracellular drug release.
    Zou P; Yu Y; Wang YA; Zhong Y; Welton A; Galbán C; Wang S; Sun D
    Mol Pharm; 2010 Dec; 7(6):1974-84. PubMed ID: 20845930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and construction of multifunctional hyperbranched polymers coated magnetite nanoparticles for both targeting magnetic resonance imaging and cancer therapy.
    Mashhadi Malekzadeh A; Ramazani A; Tabatabaei Rezaei SJ; Niknejad H
    J Colloid Interface Sci; 2017 Mar; 490():64-73. PubMed ID: 27870961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incorporation of cisplatin into PEG-wrapped ultrapurified large-inner-diameter MWCNTs for enhanced loading efficiency and release profile.
    Sui L; Yang T; Gao P; Meng A; Wang P; Wu Z; Wang J
    Int J Pharm; 2014 Aug; 471(1-2):157-65. PubMed ID: 24853461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.